Lart Bio Overview

  • Founded
  • 2016
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Lart Bio General Information

Description

Developer of a genetic scissors (calibration) technology intended for application to industrial bio-models. The company's technology has applications in bovine fertilized egg transplantation, development and supply of non-viral cell lines, development and production of genetically displaced rats, production of functional milk and albumin through genetically modified cows, development and production of animal pharmaceuticals and cosmetic materials, enabling clients to do commercialization in functional milk, animals or human markets.

Contact Information

Website
www.lartbio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • 1, 38, Nakseongdae-ro Gwanak-gu
  • Seoul, 08790
  • South Korea
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lart Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2020 Completed Out of Business
3. Early Stage VC Completed Startup
2. Accelerator/Incubator 01-Nov-2017 Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view Lart Bio’s complete valuation and funding history, request access »

Lart Bio Patents

Lart Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020534789-A Transgenic animals and transgenic embryos that produce modified nucleases Pending 16-Aug-2018 00000000 0
AU-2021232801-A1 Transgenic animals and transgenic embryos producing an engineered nuclease Pending 16-Aug-2018 00000000
AU-2019275586-B2 Transgenic animals and transgenic embryos producing an engineered nuclease Active 16-Aug-2018 00000000 0
US-20210337776-A1 Transgenic animals and transgenic embryos producing an engineered nuclease Pending 16-Aug-2018 00000000
AU-2021232802-A1 Transgenic animals and transgenic embryos producing an engineered nuclease Pending 16-Aug-2018 C12N9/22
To view Lart Bio’s complete patent history, request access »